<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00660946</url>
  </required_header>
  <id_info>
    <org_study_id>618-05</org_study_id>
    <nct_id>NCT00660946</nct_id>
  </id_info>
  <brief_title>Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin</brief_title>
  <official_title>Correlation of Point of Care INR to Laboratory INR in Hemodialysis Patients Taking Warfarin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether point of care (POC) International Normalized Ratio (INR) test results
      correlate with plasma INR measures in hemodialysis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      37 chronic hemodialysis patients being anticoagulated with warfarin require INR monitoring
      routinely.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether Point of Care INR testing would be suitable in the management of dialysis patients on chronic warfarin therapy</measure>
    <time_frame>Not an intervention study, but observational in this cohort</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine whether Point of Care INR devices maintain test accuracy in dialysis patients who are temporarily anemic (HCT &lt;32%) according to their CBC</measure>
    <time_frame>Not an intervention study, but observational in the cohort (statistics completed 1.5 yrs)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">37</enrollment>
  <condition>Anticoagulation in Dialysis Patients</condition>
  <arm_group>
    <arm_group_label>37 dialysis patients</arm_group_label>
    <description>37 chronic hemodialysis patients on warfarin requiring Laboratory INR monitoring for anticoagulation management.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Dialysis patients who undergo INR testing in the management their chronic warfarin therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic dialysis patients on chronic warfarin anticoagulation.

        Exclusion Criteria:

          -  On warfarin for less than 1 month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert W. Hoel, Pharm D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic Rochester, Mn USA</affiliation>
  </overall_official>
  <link>
    <url>http://clinicaltrials.mayo.edu</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2008</study_first_submitted>
  <study_first_submitted_qc>April 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2008</study_first_posted>
  <last_update_submitted>April 16, 2008</last_update_submitted>
  <last_update_submitted_qc>April 16, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2008</last_update_posted>
  <responsible_party>
    <name_title>Robert W. Hoel, Pharm D, Primary Investigator</name_title>
    <organization>Pharmacy Services Department, Mayo Clinic</organization>
  </responsible_party>
  <keyword>anticoagulation in dialysis patients</keyword>
  <keyword>chronic anticoagulation</keyword>
  <keyword>warfarin</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>INR</keyword>
  <keyword>Point of Care</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

